Skip to content

Dna Ligase I Deficiency C4016019

Published: July 22, 2026Updated: August 20, 2026

A rare genetic disorder impairing DNA repair, leading to growth delays and immune problems. It affects children from birth. Treatment focuses on symptom management and infection prevention.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
R69
ICD-11
MA00.0
Body system
immunologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Severe sepsis from opportunistic pathogens

Generalized symptoms

(immunologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Severe recurrent infections

(immunologic)

Growth retardation

(endocrine)

Radiation sensitivity with cutaneous lesions

(skin)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Immunoglobulin replacement therapy

Regular intravenous or subcutaneous immunoglobulin infusions to compensate for deficient antibody production and provide passive immunity against infections.

medication
2

Targeted drug therapy with dose adjustment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Infection prophylaxis and avoidance

Comprehensive infection prevention including prophylactic antibiotics when indicated, avoiding crowds and sick contacts, and maintaining up-to-date vaccinations as permitted.

lifestyle

Additional treatment options

Central venous catheter placement

Surgical placement of indwelling venous access devices for long-term immunoglobulin administration and blood product transfusions when peripheral access is problematic.

procedure

Nutritional support

Optimized nutritional intake with adequate protein, vitamins, and minerals to support immune function and overall health, potentially including supplemental nutrition when indicated.

dietary

Immunologic parameter tracking

Regular laboratory monitoring of immunoglobulin levels, lymphocyte subsets, and infection markers to guide therapy adjustments and assess disease status.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Dna Ligase I Deficiency C4016019?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Dna Ligase I Deficiency C4016019. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy